A database of FDA approved therapeutic peptides and proteins
ID1098 | ThPPIDTh1014 | NameSalmon Calcitonin | Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view | Length32 | Functional ClassificationIb | DiseaseOsteological | BrandCalcimar | CompanyN.A. | Physical AppearanceSolution | Route of AdministartionSubcutaneous or Intramuscular Injection | CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents | TargetCalcitonin receptor |
ID1100 | ThPPIDTh1014 | NameSalmon Calcitonin | Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view | Length32 | Functional ClassificationIb | DiseaseOsteological | BrandMiacalcin | CompanyNovartis | Physical AppearanceSolution | Route of AdministartionSubcutaneous or Intramuscular Injection | CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents | TargetCalcitonin receptor |
ID1142 | ThPPIDTh1020 | NameAsparaginase | Peptide SequenceQMSLQQELRYIEALSAIVET Full view | Length255 | Functional ClassificationIc | DiseaseCancer | BrandElspar | CompanyMerck & Co. Inc | Physical AppearanceLyophilized plug or powder | Route of AdministartionIntravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first. | CategoryAntineoplastic Agents | TargetL-asparagine |
ID1145 | ThPPIDTh1021 | NameThyrotropin Alfa | Peptide SequenceAlpha chain:APDVQDC< Full view | Length204 | Functional ClassificationIV | DiseaseCancer | BrandThyrogen | CompanyGenzyme Inc | Physical AppearanceLyophilized powder | Route of AdministartionIntramuscular preferably the buttocks | CategoryDiagnostic Agents | TargetThyrotropin receptor |
ID1216 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandRepronex | CompanyN.A. | Physical AppearanceSterile, lyophilized form | Route of AdministartionSubcutaneous or Intramuscular Injection. | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
ID1252 | ThPPIDTh1035 | NameGlucagon recombinant | Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view | Length29 | Functional ClassificationIV | DiseaseHormonal/Metabolic/genetic | BrandGlucaGen | CompanyNovo Nordisk | Physical AppearanceSterile, lyophilized white powder | Route of AdministartionSubcutaneous, Intramuscular, or Intravenous infusion | CategoryHypoglycemic Agents | TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor |
ID1253 | ThPPIDTh1035 | NameGlucagon recombinant | Peptide SequenceHSQGTFTSDYSKYLDSRRAQ Full view | Length29 | Functional ClassificationIV | DiseaseHormonal/Metabolic/genetic | BrandGlucagon | CompanyEli Lilly | Physical AppearancePowder | Route of AdministartionSubcutaneously or Intramuscularly Injection | CategoryHypoglycemic Agents | TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor |
ID1261 | ThPPIDTh1037 | NameBotulinum Toxin Type B | Peptide SequenceMPVTINNFNYNDPIDNNNII Full view | Length255 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandNeurobloc | CompanySolstice Neurosciences | Physical AppearanceClear and colourless to light yellow solution | Route of AdministartionIntramuscular Injection | CategoryAntidystonic Agents | TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2 |
ID1337 | ThPPIDTh1048 | NamePegaspargase | Peptide SequenceMEFFKKTALAALVMGFSGAA Full view | Length255 | Functional ClassificationIc | DiseaseCancer | BrandOncaspar | CompanyEnzon Inc | Physical AppearanceSolution | Route of AdministartionIntravenous or Intramuscular administration | CategoryAntineoplastic Agents | TargetL-asparagine |
ID1341 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandAvonex | CompanyBiogen Inc | Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector. | Route of AdministartionIntramuscular Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1372 | ThPPIDTh1055 | NameFollitropin beta | Peptide SequenceA Chain: APDVQDCPECT Full view | Length204 | Functional ClassificationIb | DiseaseHormonal disorders | BrandFollistim AQ | CompanyMerck | Physical AppearanceSterile aqueous solution | Route of AdministartionSubcutaneous or Intramuscular administration | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor |
ID1375 | ThPPIDTh1056 | NameVasopressin | Peptide SequenceCYFQNCPRG Full view | Length9 | Functional ClassificationIb | DiseaseHormonal | BrandPitressin | CompanyJHP Pharmaceuticals | Physical AppearanceSterile, aqueous solution of synthetic vasopressin | Route of AdministartionIntramuscular or Subcutaneous use | CategoryAntidiuretic Agents | TargetVasopressin V2 receptor,Vasopressin V1a receptor,Vasopressin V1b receptor |
ID1419 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandBOTOX | CompanyAllergan | Physical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type A | Route of AdministartionIntramuscular, intradetrusor and intradermal use | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
ID1420 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandDysport | CompanyIpsen Pharmaceuticals | Physical AppearanceSterile vial for reconstitution | Route of AdministartionIntramuscular Injection | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
ID1421 | ThPPIDTh1070 | NameBotulinum Toxin Type A | Peptide SequenceMPFVNKQFNYKDPVNGVDIA Full view | Length1296 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandXeomin | CompanyMERZ AESTHETICS | Physical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection. | Route of AdministartionIntramuscular Injection | CategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents | TargetGrowth hormone receptor |
ID1439 | ThPPIDTh1077 | NameUrofollitropin | Peptide SequenceAlpha chain:APDVQDCP Full view | Length203 | Functional ClassificationIb | DiseaseHormonal | BrandBRAVELLE | CompanyFerring Pharmaceuticals Inc. | Physical AppearanceSterile, lyophilized powder used after reconstitution with sterile 0.9% Sodium Chloride Injection | Route of AdministartionIntramuscular and Subcutaneous administration | CategoryFertility Agents | TargetGlutamate carboxypeptidase 2 |
ID1440 | ThPPIDTh1077 | NameUrofollitropin | Peptide SequenceAlpha chain:APDVQDCP Full view | Length203 | Functional ClassificationIb | DiseaseHormonal | BrandMetrodin | CompanyN.A. | Physical AppearanceSterile, lypholized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activity | Route of AdministartionIntramuscular injection. | CategoryFertility Agents | TargetGlutamate carboxypeptidase 2 |
ID1456 | ThPPIDTh1086 | NameInterferon Alfa-2B, Recombinant | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandINTRON® A | CompanyMerck | Physical AppearancePowder or solution | Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection | CategoryImmunosuppressive Agents | TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin |
ID1465 | ThPPIDTh1089 | NamePalivizumab | Peptide SequenceVH region: QVTLRESG< Full view | Length120 | Functional ClassificationIIIa | DiseaseInfectious | BrandSynagis | CompanyMedImmune | Physical AppearanceSterile, preservative-free liquid solution | Route of AdministartionIntramuscular injection | CategoryAntiviral Agents | TargetN.A. |
ID1500 | ThPPIDTh1103 | NameCosyntropin | Peptide SequenceACTH(1-24): SYSM Full view | Length24 | Functional ClassificationIV | DiseaseHormonal | BrandCortrosyn | CompanyAmphastar Pharmaceuticals | Physical AppearanceN.A. | Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injection | CategoryHormones and Diagnostic Agents | TargetAdrenocorticotropic hormone receptor |
ID1533 | ThPPIDTh1112 | NameNatural Alpha Interferon Or Multiferon | Peptide SequenceInteferon alpha-1: Full view | Length997 | Functional ClassificationIIa | DiseaseCancer/Infectious | BrandIntron/ Roferon-A | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionSubcutaneous injection, Intravenous injection, Intramuscular injection | CategoryN.A. | TargetN.A. |
ID1536 | ThPPIDTh1115 | NameTeicoplanin | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseInfectious | BrandTargocid | CompanyNPS Pharmaceuticals | Physical AppearanceLight yellow solid | Route of AdministartionIntravenous injection, Intramuscular injection | CategoryAnti-Bacterial Agents | TargetD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan |
ID1621 | ThPPIDTh1134 | NameAsparaginase Erwinia Chrysanthemi | Peptide SequenceADKLPNIVILATGGTIAGSA Full view | Length327 | Functional ClassificationIc | DiseaseHormonal | BrandErwinaze | CompanyEUSA Pharma | Physical AppearanceSterile, lyophilized, white powder in vials. | Route of AdministartionIntramuscular injection | CategoryEnzymes | TargetN.A. |
ID1657 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandProtropin | CompanyGenentech Inc. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntramuscular or subcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
ID1661 | ThPPIDTh1153 | NameAlefacept | Peptide SequenceHeavy Chain: CFSQQIY Full view | Length705 | Functional ClassificationIIa | DiseaseImmunological | BrandAmevive | CompanyAstellas Pharma Inc. | Physical AppearanceSterile, white-to-off-white, preservative-free, lyophilized powder | Route of AdministartionIntramuscular Injection | CategoryDermatologic and Immunosupressive agents | TargetT-cell surface antigen CD2, Complement C1r subcomponent, Complement C1q subcomponent subunit A, B, C, Low affinity immunoglobulin gamma Fc region receptor III-A,III-B, II-a, II-b, II-c |
ID1662 | ThPPIDTh1154 | NameOspA lipoprotein | Peptide SequenceMKKYLLGIGLILALIACKQN Full view | Length272 | Functional ClassificationIIIa | DiseaseInfectious | BrandLymerix | CompanySmithKline Beecham | Physical AppearanceSterile suspension | Route of AdministartionIntramuscular Injection | CategoryVaccines | TargetToll-like receptor 2 |
ID1664 | ThPPIDTh1156 | NameAbarelix | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseHormonal | BrandPlenaxis | CompanySpeciality european pharma | Physical AppearanceWhite to off-white sterile dry powder | Route of AdministartionIntramuscular Injection | CategoryAnti-Testosterone Agents | TargetGonadotropin-releasing hormone receptor |
ID1758 | ThPPIDTh1183 | NameHepatitis B immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHepagam B | CompanyCangene Bio Pharma Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular; Intravenous | CategoryNA | TargetHBsAg |
ID1762 | ThPPIDTh1183 | NameHepatitis B immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHyperhep B S/d | CompanyGRIFOLS USA, LLC | Physical AppearanceInjection | Route of AdministartionIntramuscular | CategoryNA | TargetHBsAg |
ID1763 | ThPPIDTh1183 | NameHepatitis B immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandNabi-HB | CompanyBiotest Pharmaceuticals Corporation | Physical AppearanceInjection | Route of AdministartionIntramuscular | CategoryNA | TargetHBsAg |
ID1767 | ThPPIDTh1185 | NameHuman clostridium tetani toxoid immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseInfectious Disease | BrandHypertet S/d | CompanyGRIFOLS USA, LLC | Physical AppearanceInjection | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1768 | ThPPIDTh1186 | NameHuman rabies virus immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHyperab Rabies Immune Globulin Human | CompanyCutter Med & Biol, Division Of Miles Canada Ltd. | Physical AppearanceLiquid | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1769 | ThPPIDTh1186 | NameHuman rabies virus immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHyperrab S/d | CompanyGrifols Therapeutics Inc | Physical AppearanceSolution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1770 | ThPPIDTh1186 | NameHuman rabies virus immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandImogam Rabies Inj 150unit/ml | CompanyPasteur mÉrieux Serums Et Vaccins, s.a. | Physical AppearanceClear, pale yellow to light brown liquid | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1771 | ThPPIDTh1186 | NameHuman rabies virus immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandImogam Rabies Pasteurized | CompanySanofi Pasteur Limited | Physical AppearanceSolution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1772 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandHyp Rho D Inj 16.5% | CompanyCutter Med & Biol, Division Of Miles Canada Ltd. | Physical Appearanceliquid | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1773 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandHyperrho S/d Full Dose | CompanyGRIFOLS USA, LLC | Physical AppearanceSoution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1774 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandHyperrho S/d Mini-dose | CompanyGRIFOLS USA, LLC | Physical AppearanceSolution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1775 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandMicrhogam Ultra-filtered Plus | CompanyKedrion Melville, Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1776 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandRhogam Ultra-filtered Plus | CompanyKedrion Melville, Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular | CategoryNA | TargetNA |
ID1777 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandRhophylac | CompanyCsl Behring Ag | Physical AppearanceSolution | Route of AdministartionIntramuscular; Intravenous | CategoryNA | TargetNA |
ID1778 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandWinrho Sdf | CompanyAptevo Biotherapeutics Llc | Physical Appearancekit | Route of AdministartionIntramuscular; Intravenous | CategoryNA | TargetNA |
ID1779 | ThPPIDTh1187 | NameHuman Rho(D) immune globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandWinrho Sdf (liquid Formulation) | CompanyAptevo Biotherapeutics Llc | Physical Appearanceliquid | Route of AdministartionIntramuscular; Intravenous | CategoryNA | TargetNA |
ID1793 | ThPPIDTh1190 | NameImmune Globulin Human | Peptide SequenceIGG1: PSALTQPPSASGSL Full view | Length1338 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandGamastan | CompanyCutter Med & Biol, Division Of Miles Canada Ltd. | Physical Appearanceliquid | Route of AdministartionIntramuscular | CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents | TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5. |
ID1794 | ThPPIDTh1190 | NameImmune Globulin Human | Peptide SequenceIGG1: PSALTQPPSASGSL Full view | Length1338 | Functional ClassificationIIIb | DiseaseImmunological Disorders | BrandGamastan S/d | CompanyGRIFOLS USA, LLC | Physical AppearanceInjection | Route of AdministartionIntramuscular | CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents | TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5. |
ID1834 | ThPPIDTh1223 | NameChorionic Gonadotropin (Human) | Peptide SequenceAlpha Chain: APDVQDC Full view | Length237 | Functional ClassificationIa | DiseaseHormonal Disorders | BrandPregnyl | CompanyPhysicians Total Care, Inc. | Physical AppearanceInjection, Solution | Route of AdministartionIntramuscular, Subcutaneous | CategoryHormones | TargetLutropin-choriogonadotropic hormone receptor |
ID1840 | ThPPIDTh1229 | NameHepatitis A Vaccine | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandAvaxim | CompanySanofi Pasteur Limited | Physical AppearanceSuspension | Route of AdministartionIntramuscular | CategoryVaccine | TargetNA |
ID1841 | ThPPIDTh1229 | NameHepatitis A Vaccine | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandHavrix | CompanyDispensing Solutions, Inc. | Physical AppearanceSuspension | Route of AdministartionIntramuscular | CategoryVaccine | TargetNA |
ID1842 | ThPPIDTh1230 | NameHuman Varicella-Zoster Immune Globulin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIIIa | DiseaseInfectious Disease | BrandVARIZIG | CompanyNA | Physical Appearancelyophilized powder for solution | Route of AdministartionIntramuscular | CategoryAntibody | Targetvaricella zoster virus |